Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Methodology Series Module 4: Clinical Trials.

Maninder Singh Setia1

  • 1Epidemiologist, MGM Institute of Health Sciences, Navi Mumbai, Maharashtra, India.

Indian Journal of Dermatology
|August 12, 2016
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

367
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
367
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

201
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
201
Hazard Ratio01:12

Hazard Ratio

686
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
686
Blinding01:11

Blinding

4.0K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
4.0K
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

354
Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...
354
Crossover Experiments01:16

Crossover Experiments

4.7K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
4.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of Spaeth/Richman Contrast Sensitivity and Pelli-Robson Tests for Assessing Contrast Sensitivity in Patients with Glaucoma.

Journal of ophthalmic & vision research·2025
Same author

Comparison of Post-Operative Outcomes between IOP-20 and IOP-50 in Phacoemulsification with Active Fluidics System: Randomized Single Blinded Trial.

Clinical ophthalmology (Auckland, N.Z.)·2025
Same author

Postoperative Rotation and Refractive Efficacy of Toric Intraocular Lenses After Phacoemulsification Cataract Surgery.

Ophthalmology and therapy·2025
Same author

Prevalence of Hypertension and Its Associated Factors Among Adult People Living with HIV/AIDS at Anti-Retroviral Treatment (ART) Centers in Mumbai, India.

HIV/AIDS (Auckland, N.Z.)·2025
Same author

The Modified History of Juvenile Rheumatic Mitral Stenosis Following Percutaneous Transmitral Commissurotomy: Intermediate-Term Outcomes From a Decadal Follow-Up Study.

Heart, lung & circulation·2024
Same author

Evaluation of Intermediate Visual Outcomes in Eyes Implanted with Bilateral Advanced Monofocal Intraocular Lens Targeting for Mini-Monovision and Its Association with Age and Corneal Asphericity.

Clinical ophthalmology (Auckland, N.Z.)·2024
Same journal

Severe Irritant Contact Dermatitis to <i>Cyperus Scariosus</i>: A Side Effect of Ayurvedic <i>Plava</i>.

Indian journal of dermatology·2026
Same journal

Extensive Grouped Papules on the Vulva in a Patient with Cervical Cancer.

Indian journal of dermatology·2026
Same journal

Facial Melanosis: A Comprehensive Review of Uncommon and Common Presentations with Personal Experience.

Indian journal of dermatology·2026
Same journal

Exploring AI as a Diagnostic Tool in Medical Imaging for Dermatopathological Diseases.

Indian journal of dermatology·2026
Same journal

Carotid Intima-Media Thickness and Retrobulbar Blood Flow in Patients with Psoriasis.

Indian journal of dermatology·2026
Same journal

Pyoderma Gangrenosum-Like Ulcer Secondary to Antiphospholipid Syndrome.

Indian journal of dermatology·2026
See all related articles

This study explains clinical trial designs, including parallel, cross-over, factorial, and withdrawal designs. It highlights the importance of randomization and blinding to minimize bias in medical research.

Area of Science:

  • Clinical research methodology
  • Medical trial design and analysis

Background:

  • Clinical trials are essential for evaluating interventions.
  • Participants are typically divided into intervention and control groups.
  • Understanding different trial designs is crucial for accurate interpretation.

Purpose of the Study:

  • To outline various clinical trial designs.
  • To explain the role of randomization and blinding.
  • To emphasize the importance of adhering to reporting guidelines.

Main Methods:

  • Description of common clinical trial designs: parallel, cross-over, factorial, and withdrawal.
  • Explanation of randomization as an allocation procedure.
  • Discussion of blinding to minimize bias.
Keywords:
Blindingclinical trialsdesignrandomisation

Related Experiment Videos

Main Results:

  • Clinical trials utilize diverse designs to assess interventions.
  • Randomization ensures unbiased group allocation.
  • Blinding minimizes bias by concealing treatment allocation.

Conclusions:

  • Familiarity with trial designs, randomization, and blinding is vital for researchers.
  • Adherence to CONSORT statement and clinical trial registries is recommended.
  • Proper methodology ensures the reliability of clinical trial findings.